Unicycive Therapeutics Inc [NASDAQ: UNCY] traded at a low on Tuesday, posting a -8.96 loss after which it closed the day’ session at $0.69.
The results of the trading session contributed to over 10976084 shares changing hands. Over the past one week, the price volatility of Unicycive Therapeutics Inc stands at 8.52% while the volatility over the past one month is 14.61%.
The market cap for UNCY stock reached $82.84 million, with 119.75 million shares outstanding and 100.03 million shares in the current float. Compared to the average trading volume of 2.73M shares, UNCY reached a trading volume of 10976084 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Unicycive Therapeutics Inc [UNCY]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNCY shares is $6.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNCY stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Unicycive Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 21, 2025. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on April 04, 2024, representing the official price target for Unicycive Therapeutics Inc stock.
The Average True Range (ATR) for Unicycive Therapeutics Inc is set at 0.11 The Price to Book ratio for the last quarter was 7.30, with the Price to Cash per share for the same quarter was set at 0.16.
How has UNCY stock performed recently?
Unicycive Therapeutics Inc [UNCY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 29.05. With this latest performance, UNCY shares gained by 15.24% in over the last four-week period, additionally sinking by -7.20% over the last 6 months – not to mention a rise of 4.84% in the past year of trading.
#####
Unicycive Therapeutics Inc [UNCY]: Deeper insight into the fundamentals
Unicycive Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.64 and a Current Ratio set at 1.64.
Insider trade positions for Unicycive Therapeutics Inc [UNCY]
The top three institutional holders of UNCY stocks are: VIVO CAPITAL, LLC with ownership of 3.47 million shares, which is approximately 9.9395%. LOGOS GLOBAL MANAGEMENT LP, holding 3.47 million shares of the stock with an approximate value of $$1.74 million in UNCY stocks shares; and LOGOS GLOBAL MANAGEMENT LP, currently with $$1.41 million in UNCY stock with ownership which is approximately 8.0783%.
